Skip to main content
Equibles
HUM logo

HUM · Humana Inc

Track HUM — free

Use HUM with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HUM

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$380.54 +2.52 (+0.67%)
Market Cap
$45.39B
Shares
120.06M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$378.02 Open$385.00 Day$371.50–387.61 52W close$163.67–409.42 Avg vol 30d1.4M Short int3.7M · 3.0% float · 2.2d Short vol32% Last earningsNov 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Nov 6, 2026 Scheduled · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 29, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +39%
      above
      Price vs 50-day avg −1%
      below
      RSI (14) 49
      neutral
      MACD trend Positive
      52-week position 87%
      near high
      Momentum
      relative strength
      Strong
      1-month return −5%
      trailing
      6-month return +102%
      trailing
      YTD return +48%
      this year
      Relative strength +91%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $383 › 200d $271 — 50d above 200d
      Institutional flow Accumulating
      +18% holders QoQ · +242 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      3.05% of float · ▼ -13.9% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      930 holders — mid 3-yr range
      Squeeze score 50
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +10%
      Y/Y
      EPS growth −1%
      Y/Y
      Free cash flow $375.0M
      Valuation P/E 40.3
      rich
      Buyback $2.7B
      remaining
      Balance sheet $8.2B
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 49%
      annualized · 1-yr
      Max drawdown −48%
      past year
      ATR 3.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 29, 2026
      GAAP EPS · FY 2026 Initiated at least $6.52
      prior FY $9.84 midpoint −33.7% Y/Y
      Adjusted EPS · FY 2026 Initiated at least $9.00
      Individual Medicare Advantage membership change · FY 2026 Initiated 25%
      CenterWell segment income from operations · FY 2026 Initiated $1.3B – $1.8B
      CenterWell segment income from operations · FY 2026 Initiated $1.5B – $2B
      Effective Tax Rate · FY 2026 Initiated 25.5%
      Total Revenues Consolidated · FY 2026 Initiated at least $160B
      prior FY $129.66B midpoint +23.4% Y/Y
      Individual Medicare Advantage membership growth · FY 2026 Initiated 25%
      Prior guidance period ended · from the 8-K filed Feb 11, 2026
      First quarter earnings as a percentage of expected FY 2026 Adjus · Q1 2026 110% – 115%
      Insurance segment benefit ratio · Q1 2026 89.99%
      Guided vs delivered · last 1 settled
      GAAP EPS FY 2025
      guided $12.26
      $9.84 Miss −19.7%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +39% Bullish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      49 Neutral
      MACD trend
      Positive Bullish
      52-week position
      87% Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $383 › 200d $271 — 50d above 200d
      Institutional flow Accumulating
      +18% holders QoQ · +242 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      3.05% of float · ▼ -13.9% MoM · 2.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      930 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $164 Now $378 · 87% Range high $409
      vs 200-day avg +39% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted consolidated operating cost ratio non-GAAP 9.7% 2Q26 —
      Adjusted EPS non-GAAP $7.61 2Q26 —
      Benefit ratio 91.1% 2Q26 —
      CenterWell Home Health same store admissions YTD growth 3% 2Q26 YTD —
      CenterWell Primary Care patients 622,000 as of June 30, 2026 —
      CenterWell Segment Adjusted (non-GAAP) Income from operations non-GAAP $514M 2Q26 —
      CenterWell segment Operating cost ratio 93.4% For the six months ended June 30, 2026 —
      Consolidated GAAP benefit ratio 90.2% For the six months ended June 30, 2026 —
      Days in Claims Payable (DCP) 33.1 2Q26 —
      Debt to capitalization ratio 42.7% as of June 30, 2026 —
      Dental—ASO 314.1K As of June 30, 2026 —
      Dental—fully-insured 2.19M As of June 30, 2026 —
      Episodic Admissions 168,800 For the six months ended June 30, 2026 —
      Group MA YTD membership growth 159,000 2Q26 YTD —
      Group Medicare Advantage 727.2K As of June 30, 2026 —
      Individual MA YTD membership growth 1,204,000 2Q26 YTD —
      Individual Medicare Advantage 6.45M As of June 30, 2026 —
      Individual Stand-Alone Part D (PDP) YTD membership growth 1,139,000 2Q26 YTD —
      Insurance segment Benefit ratio 91.2% 2Q26 —
      Insurance segment Operating cost ratio 7.2% For the six months ended June 30, 2026 —
      Medicaid YTD membership growth 93,000 2Q26 YTD —
      Medicare stand-alone PDP 3.95M As of June 30, 2026 —
      Medicare Supplement 551.5K As of June 30, 2026 —
      Military services 4.63M As of June 30, 2026 —
      Operating cash flows $3.22B YTD 2026 —
      Operating centers 398 as of June 30, 2026 —
      Operating cost ratio 9.8% 2Q26 —
      Operating cost ratio (Consolidated) 10% For the six months ended June 30, 2026 —
      Other supplemental benefits 422.8K As of June 30, 2026 —
      Primary Care Center Count (Total) 398 As of June 30, 2026 —
      Primary Care Patients Served (Total) 622,000 As of June 30, 2026 —
      Primary Care Providers (Total) 1,478 As of June 30, 2026 —
      State-based contracts and other 1.6M As of June 30, 2026 —
      Total Admissions - Same Store 225,398 For the six months ended June 30, 2026 —
      Total Dental 2.51M As of June 30, 2026 —
      Total Medical Membership 17.91M As of June 30, 2026 —
      Total Medicare 11.13M As of June 30, 2026 —
      Total Medicare Advantage 7.18M As of June 30, 2026 —
      Total Specialty Membership 4.9M As of June 30, 2026 —
      Vision 1.97M As of June 30, 2026 —
      CenterWell Senior Primary Care MaxHealth acquired centers 54 1Q26 —
      CenterWell Senior Primary Care MaxHealth acquired patients 59,000 1Q26 —
      CenterWell Senior Primary Care patient growth 110,500 1Q26 —
      State-based contracts membership growth 50,000 1Q26 —
      CenterWell Senior Primary Care patients growth 100,600 FY 2025 —
      CenterWell Senior Primary Care patients growth percent 25% FY 2025 —
      Consolidated Adjusted (non-GAAP) benefit ratio non-GAAP 90.2% FY 2025 —
      Insurance segment Adjusted (non-GAAP) benefit ratio non-GAAP 90.4% FY 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Healthcare Plans — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HUM
      Humana Inc
      this stock
      		$45.39B +47.6% +10.1% 40.3 3.0%
      UNH
      Unitedhealth Group Inc
      		 $345.44B +17.7% +11.8% — 1.7%
      CVS
      CVS HEALTH Corp
      		 $119.95B +18.0% +7.8% 24.8 1.5%
      ELV
      Elevance Health, Inc.
      		 $87.01B +13.7% +12.5% 17.8 2.6%
      CI
      Cigna Group
      		 $74.37B +0.8% +11.2% 11.7 1.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      930
      % held
      104.9%
      Net QoQ
      +3.0M sh
      Top holder
      Dodge & Cox
      Held Float
      View
      Held by Funds
      Fund positions
      836
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.7M
      Days to cover
      2.2d
      Change
      -592.4K sh
      View
      Short Volume
      Short vol %
      32%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1
      Value
      $365
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      39.5%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      Alan Armstrong
      Amount
      $1.0K–$15.0K
      Traded
      Mar 27, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $129.7B
      Net income (FY)
      $1.2B
      EPS diluted
      $9.84
      View
      Buybacks
      Authorized
      $3.0B
      Remaining
      $2.7B
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 29, 2026
      This year
      14
      View
      Proposed Sales
      Value
      $2.7M
      Shares
      11.0K
      Filed
      Apr 8, 2025
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Nov 6, 2026
      Last call
      Jul 29, 2026
      View
      Investor Relations
      Upcoming events
      2
      View

      Performance

      5D 20D 120D MTD YTD
      HUM -2.8% -4.9% +102.3% +3.9% +47.6%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY -2.3% -7.8% +90.8% +0.9% +34.8%

      Capital returns

      Latest dividend
      $0.885 / share · ex Jun 26, 2026
      Raised 12.3%
      Paid (TTM)
      $3.54 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.94%
      Buyback program · as of Jul 28, 2026
      Authorized
      $3.00B
      Spent (derived)
      $300.00M
      Remaining
      $2.70B
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 49071 CUSIP 444859102 13F (30d) 830 filings 801 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)